Canada markets closed

First Wave BioPharma, Inc. (FWBI)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
2.7400+0.0100 (+0.37%)
At close: 04:00PM EDT
2.8200 +0.08 (+2.92%)
After hours: 05:37PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 5.55M
Enterprise Value 2.66M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)1.54
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -0.17

Trading Information

Stock Price History

Beta (5Y Monthly) 1.21
52-Week Change 3-95.11%
S&P500 52-Week Change 322.36%
52 Week High 362.4000
52 Week Low 32.4200
50-Day Moving Average 34.8052
200-Day Moving Average 36.2531

Share Statistics

Avg Vol (3 month) 3101.74k
Avg Vol (10 day) 364.24k
Shares Outstanding 52.03M
Implied Shares Outstanding 62.24M
Float 81.91M
% Held by Insiders 17.69%
% Held by Institutions 14.07%
Shares Short (Apr 15, 2024) 440k
Short Ratio (Apr 15, 2024) 40.82
Short % of Float (Apr 15, 2024) 41.98%
Short % of Shares Outstanding (Apr 15, 2024) 41.98%
Shares Short (prior month Mar 15, 2024) 413.85k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:20
Last Split Date 3Dec 18, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-159.98%
Return on Equity (ttm)-497.87%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -15.74M
Net Income Avi to Common (ttm)-16.1M
Diluted EPS (ttm)-47.8800
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)3.71M
Total Cash Per Share (mrq)1.83
Total Debt (mrq)826.84k
Total Debt/Equity (mrq)22.95%
Current Ratio (mrq)1.58
Book Value Per Share (mrq)2.31

Cash Flow Statement

Operating Cash Flow (ttm)-12.38M
Levered Free Cash Flow (ttm)-7.76M